在疾病中,Ganoderma lucidum及其活性成分对肠道菌群的调节作用
Xinjie Qin1,2, Zinan Fang1,2, Jinkang Zhang1,2
1College of Food Engineering, Jilin Engineering Normal University, Changchun, China.
Frontiers in microbiology
|April 4, 2024
概括
药用Ganoderma lucidum及其生物活性化合物可以调节肠道菌群,以帮助管理诸如高血糖症和肥胖等代谢疾病. 本综述探讨了它的机制和治疗潜力.
科学领域:
- 菌类学 菌类学是指菌类学.
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甘菌 (Ganoderma lucidum) 是一种有价值的药用真菌,含有多糖和三类等生物活性成分.
- 这些成分影响肠道微生物群,可能缓解与肠道失调相关的代谢疾病.
- 目前还没有对Ganoderma lucidum肠道菌群调节机制进行系统审查.
研究的目的:
- 在代谢性疾病中系统地审查Ganoderma lucidum对肠道菌群的影响.
- 通过肠道菌群调节来管理疾病的Ganoderma lucidum活性成分的研究进行总结.
- 在医学和健康食品中探索Ganoderma lucidum的治疗原理和潜在应用.
主要方法:
- 文献综述研究的Ganoderma lucidum,肠道微生物群和代谢疾病.
- 分析生物活性成分及其对肠道菌群的影响.
- 综合关于疾病缓解机制的当前研究.
主要成果:
- 光及其成分在调节肠道微生物群的组成和功能方面显示出显著的潜力.
- 证据表明,通过肠道菌群调节来管理高血糖症,高脂血症和肥胖症的有效性.
- 该审查强调了特定的生物活性化合物及其对肠道微生物群的向影响.
结论:
- 光及其活性化合物通过向肠道微生物群,为代谢性疾病提供了有希望的治疗策略.
- 对其机制的进一步研究可以释放其在临床应用和健康产品中的全部潜力.
- 本综述为研究人员提供了全面的概述,以探索甘光在肠道健康和疾病管理中的作用.
相关概念视频
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
510
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
510
01:20Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
210
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
210
01:17Drugs for Treatment of Diarrhea-Predominant IBS
166
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
166
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
252
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
252
01:21Drugs for Treatment of Constipation-Predominant IBS
162
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
162
01:29Bacterial Flora of the Large Intestine
436
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
436